Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Total Current Liabilities (2016 - 2025)

CV Sciences (CVSI) has disclosed Total Current Liabilities for 14 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 18.15% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, down 18.15% year-over-year, with the annual reading at $5.0 million for FY2025, 18.15% down from the prior year.
  • Total Current Liabilities hit $5.0 million in Q4 2025 for CV Sciences, up from $4.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $14.9 million in Q1 2021 to a low of $4.8 million in Q3 2025.
  • Historically, Total Current Liabilities has averaged $9.0 million across 5 years, with a median of $6.1 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: rose 24.34% in 2021 and later tumbled 56.85% in 2023.
  • Year by year, Total Current Liabilities stood at $14.5 million in 2021, then fell by 7.93% to $13.3 million in 2022, then plummeted by 54.07% to $6.1 million in 2023, then fell by 0.1% to $6.1 million in 2024, then decreased by 18.15% to $5.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for CVSI at $5.0 million in Q4 2025, $4.8 million in Q3 2025, and $5.7 million in Q2 2025.